Skip to main content
. Author manuscript; available in PMC: 2012 Feb 1.
Published in final edited form as: Cancer Res. 2010 Dec 8;71(3):1019–1028. doi: 10.1158/0008-5472.CAN-10-1855

Figure 7. Enhancement of gemcitabine resistance by MT1-MMP in PDAC.

Figure 7

Our data demonstrate that PDAC cells in the collagen microenvironment express MT1-MMP, causing increased ERK1/2-dependent HMGA2 expression. This signaling pathway allows PDAC cells to resist gemcitabine-induced cell cycle-and proliferation-arrest, both in vitro and in vivo.